Dec 10, 2020

Lysis Matrices for Preclinical Samples

The most critical factor to consider is the resilience of your sample. Many biological samples are soft and easy to lyse, such as mammalian cells and brain tissue, but others are very resistant to lysing and homogenization, such as hair and skin. Tougher samples often require more aggressive lysing matrices and sometimes unique conditions.

Dec 10, 2020

Research Review: Oral Microbiota and Breast Cancer

The microbiome is a complex community of trillions of microorganisms that influence human biology in both positive and negative ways, including cancer development and progression.
Fusobacterium nucleatum, a gram-negative anaerobe associated with periodontal disease, originates in the oral microbial community and is prevalent in colorectal cancer (CRC)¹.

Dec 11, 2020

How to Prepare Aquatic DNA Samples

Environmental samples consist of both biotic and abiotic components, representing a diverse community of microbes, animals and plants. Environmental DNA (eDNA) is an increasingly valuable resource for exploring and monitoring aquatic ecosystems and studying biodiversity.
With aquatic samples being so diverse in both composition and turbidity, there are a multitude of approaches that can be used to extract DNA. Here we describe key methods—preprocessing, collection and extraction—to get high-quality DNA from your samples for downstream applications, such as next generation sequencing and metabarcoding.

Dec 10, 2020

Lysing Matrices for Agricultural Samples

Mechanical homogenization using bead beating technology, such as MP Bio’s lysing matrices, is an effective method for cell lysis. Lysing matrices differ by size, shape, material, and composition.
When selecting the optimal lysis beads for your project, consider the toughness of your sample type, the particle size you wish to obtain, and the stability of your target molecule.

Sep 18, 2020

MP Biomedicals facility in India is awarded both ISO 9001:2015 and WHO GMP certification

MP Biomedicals proudly announces the recent award of ISO 9001:2015 and WHO GMP certifications for manufacturing facility located in Navi Mumbai, in Maharashtra state of India.
Clients are assured global quality products with high consistency to support their manufacturing and research needs in Pharmaceutical and Diagnostic industries. Supported by qualified team of QA and QC professionals, MP Biomedicals meets highly stringent requirements with complete documentation and traceability.

Aug 25, 2020

MP Biomedicals develops two new high-performance DNA extraction kits to advance both environmental and gut microbiome research

MP Biomedicals announced the launch of two new high-performance DNA extraction kits – SPINeasy™ DNA Kit for Soil and MagBeads FastDNA™ Kit for Feces for Feces – to advance your microbiome research.
Microbiome research has wide applications in agriculture, biofuel, ecology, environment remediation and healthcare. The characterization of soil and gut microbiome requires the extraction of genetic materials, but it is not an easy process as both sources have complex content which can hinder scientists from getting sufficient yield of DNA or DNA of high purity that can be used directly for downstream application.

Jul 27, 2020

MP Biomedicals and A*Star Singapore Co-develop Rapid Antibody Point-of-Care Test Kit for SARS-CoV-2

ASSURE® SARS-CoV-2 IgG/IgM Rapid Test kit detects antibodies produced by the human immune system in response to exposure to COVID-19.

Jun 05, 2020

FastPrep-24™ Classic used in COVID-19 Vaccine Development

MP Biomedicals FastPrep® Instruments help expedite COVID-19 current vaccine research with INOVIO Pharmaceuticals, University of Oxford and CSIRO in Australia.

MP Biomedicals is proud to see the FastPrep-24 Classic has been instrumental in SARS-CoV-2 therapeutic research. INOVIO Pharmaceuticals, together with University of Oxford and researchers at Commonwealth Scientific and Industrial Research Organization (CSIRO) in Australia, were featured on 9 News Australia showcasing their COVID-19 vaccine development.

Mar 03, 2020

MP Biomedicals Announces Launch of SARS-CoV-2 Products

MP Biomedicals, a division of Valiant Co., Ltd., is stepping in to support scientists worldwide in understanding SARS-CoV-2 and discovering solutions to combat COVID-19 by launching several new monoclonal antibodies and recombinant antigens.

Mar 06, 2019

Article in Genetic Engineering & Biotechnology, “High-Performance Density Gradient Media for Purification of Leukocytes from Blood”.

MP Bio describes formulations that isolate mononuclear and polymorphonuclear leukocytes with high yield and viability using Lymphocyte Separation Medium (LSM™), LymphoSep™, and Mono-Poly™ Resolving Medium.